A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension

Clinical trial NCT02020512 · COMPLETED

Trial details

NCT number: NCT02020512
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Glaucoma, Open-Angle Ocular Hypertension

Start date: 2011-07-01
Primary completion: 2012-12-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.